Hemostasis Valve Market Forecasts to 2028 – Global Analysis By Type (One-handed Hemostasis Valves, Double Y-connector Hemostasis Valves, Hemostasis Valve Y-connectors and Other Types), Application, End User and By Geography

Hemostasis Valve Market Forecasts to 2028 – Global Analysis By Type (One-handed Hemostasis Valves, Double Y-connector Hemostasis Valves, Hemostasis Valve Y-connectors and Other Types), Application, End User and By Geography

According to Stratistics MRC, the Global Hemostasis Valve Market is accounted for $172.2 billion in 2022 and is expected to reach $255.6 billion by 2028 growing at a CAGR of 6.8% during the forecast period. Hemostasis valve sets are used to connect or introduce catheters and guide wires during surgery. When interventional devices are placed into the human circulatory system, hemostasis valve is intended to be employed as a conduit. In neuroendovascular surgeries, a hemostasis valve is typically employed to lower the risk of thrombosis. A new hemostasis valve that is intended to minimise blood loss has also been developed.

According to the World Health Organization (WHO), CVDs are responsible for approximately 17.9 million deaths each year, making them the leading cause of death globally.

Market Dynamics:

Driver:

Rise in prevalence of cardiovascular diseases

Hemostasis valves are frequently employed during cardiovascular procedures to stop blood loss and lessen the possibility of problems. A category of conditions known as cardiovascular illnesses damage the heart and blood arteries. By assisting surgeons in controlling bleeding and reducing complications, hemostasis valves are essential in these operations. Increase in prevalence of cardiovascular diseases is one of the key drivers of the market.

Restraint:

Lack of awareness

The general population has little knowledge of hemostasis valves. There is a shortage of knowledge on these gadgets. The availability of hemostasis valves is limited. The body is fitted with hemostasis valves to regulate bleeding. A blood clot developing in the valve is a possibility known as valve thrombosis. Additionally, it is anticipated that technical issues and the potential for air embolism caused by the hemostasis valve may restrain market expansion.

Opportunity:

Growth in demand for minimally invasive surgeries

Smaller incisions during surgery are referred to as minimally invasive techniques. Due to the advantages these procedures provide over more conventional procedures, they are becoming more and more popular. Due to its role in regulating bleeding during minimally invasive surgeries, this valve is a crucial part of those operations. Therefore, a rise in the use of less invasive procedures is driving market expansion.

Threat:

High Cost of Hemostasis Valves

Metals, polymers, and ceramics are just a few of the materials used to make hemostasis valves. The production process is intricate, and these materials are pricey. Hemostasis valves are hence costly. One of the biggest issues facing the market is the price of hemostasis valves. The expensive price of hemostasis valves and the scarcity of qualified doctors, however, are limiting market expansion.

Covid-19 Impact

Numerous people are becoming infected with COVID-19, which has led to a sharp increase in the amount of available management equipment. There are many different equipment, but respiratory support devices such atomizers, oxygen generators, life support machines, and monitors are among the most commonly utilised medical devices in critical clinical treatment. Gloves, masks, and protective eyewear are just a few of the medical products that might be employed as personal protection equipment as a result of the pandemic. Both medical experts and the general public have noticed an increase in such devices and personal protection equipment as preventative measures.

The hemostasis valve y-connectors segment is expected to be the largest during the forecast period

The hemostasis valve y-connectors segment is estimated to have a lucrative growth, due to they are increasingly used in various medical procedures. Y-connectors give catheterization procedures a reliable seal. They are very simple to use and require little training for medical personnel. Furthermore, superior designs that offer greater efficacy and a lower risk of infection have been made possible by technological breakthroughs in hemostasis valves.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increase in prevalence of cardiovascular diseases. This is partly because there are more hospitals in developing nations as a result of initiatives for infrastructure construction and a rise in the number of patients who want to have surgery in a hospital. Infrastructures including wholesome food, support services, a positive environment, and patient safety will play a significant role in raising demand for hospitals.

Region with Largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the rise in prevalence of cardiovascular diseases. The market value is also being boosted by rising healthcare costs and an increase in demand for minimally invasive surgeries. Regional investment is also due to growing sector leaders' interest and spending as well as continuous collaborative projects. Additionally, expanding hospital numbers and medical tourism are some of the elements influencing the development of the regional sector.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to the elevated prevalence of cancer coupled with strategic policies and investment in the healthcare sector. This is brought on by the rising incidence of cardiovascular disorders and patients' choice for minimally invasive procedures. The region's growth is being fueled by reasons such as an increase in senior population, interventional surgery demand, and health awareness.

Key players in the market

Some of the key players profiled in the Hemostasis Valve Market include Terumo Corporation, Freudenberg Medical, Boston Scientific Corporation, Merit Medical Systems, Teleflex Incorporated, B. Braun Melsungen, Argon Medical, DeRoyal Industries, Abbott Laboratories , Argon Medical Devices, Excel Medical Products, Qosina Corporation and Scitech.

Key Developments:

In December 2020, Teleflex Incorporated, a leading global provider of health – care items and services, announced that it has completed the announced acquisition of Z-Medica, LLC, a sector manufacturing company of hemostatic products.

In November 2020, Freudenberg Medical recently built its worldwide headquarters in Massachusetts and its new medical production facility in Beverly, Massachusetts.

Types Covered:
• One-handed Hemostasis Valves
• Double Y-connector Hemostasis Valves
• Hemostasis Valve Y-connectors
• Other Types

Applications Covered:
• Angioplasty
• Angiography
• Interventional Cardiology & Radiology
• Other Applications

End Users Covered:
• Hospitals
• Ambulatory Surgery Centers
• Specialty Clinics
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements